US Stock MarketDetailed Quotes

SLXNW BIOMOTION SCIENCES C/WTS EXP 14/08/2029 (TO PUR COM)

Watchlist
  • 0.096
  • +0.026+36.95%
Close Aug 23 16:00 ET
0Market Cap0.00P/E (TTM)

BIOMOTION SCIENCES C/WTS EXP 14/08/2029 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1.07M
-92.32%-1.75M
-35.80%-4.53M
-911K
-3.34M
Net income from continuing operations
---1.49M
-91.52%-1.42M
-46.44%-5.11M
---743K
---3.49M
Operating gains losses
----
----
---1K
----
----
Depreciation and amortization
--7K
-46.67%8K
-21.05%45K
--15K
--57K
Other non cash items
--83K
747.62%136K
218.66%318K
---21K
---268K
Change In working capital
--302K
-160.31%-505K
-63.60%87K
---194K
--239K
-Change in receivables
--2K
-500.00%-44K
145.00%18K
--11K
---40K
-Change in prepaid assets
---63K
-1,742.86%-129K
-179.28%-329K
---7K
--415K
-Change in payables and accrued expense
--364K
-149.02%-381K
993.88%438K
---153K
---49K
-Change in other working capital
---1K
208.89%49K
54.02%-40K
---45K
---87K
Cash from discontinued investing activities
Operating cash flow
---1.07M
-92.32%-1.75M
-35.80%-4.53M
---911K
---3.34M
Investing cash flow
Cash flow from continuing investing activities
0
-101.18%-6K
209.35%573K
507K
-524K
Net PPE purchase and sale
--0
---6K
265.00%66K
--0
---40K
Net investment purchase and sale
--0
--0
204.75%507K
--507K
---484K
Cash from discontinued investing activities
Investing cash flow
--0
-101.18%-6K
209.35%573K
--507K
---524K
Financing cash flow
Cash flow from continuing financing activities
0
-81.03%522K
0
2.75M
Net preferred stock issuance
--0
----
-81.01%522K
----
--2.75M
Proceeds from stock option exercised by employees
--0
----
--0
--0
--3K
Cash from discontinued financing activities
Financing cash flow
--0
--0
-81.03%522K
--0
--2.75M
Net cash flow
Beginning cash position
--2.83M
-44.10%4.65M
-17.59%8.31M
--8.31M
--10.08M
Current changes in cash
---1.07M
-335.15%-1.76M
-210.21%-3.43M
---404K
---1.11M
Effect of exchange rate changes
---19K
-394.74%-56K
65.52%-230K
--19K
---667K
End cash Position
--1.75M
-64.27%2.83M
-44.10%4.65M
--7.92M
--8.31M
Free cash flow
---1.07M
-92.97%-1.76M
-34.55%-4.54M
---911K
---3.38M
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1.07M-92.32%-1.75M-35.80%-4.53M-911K-3.34M
Net income from continuing operations ---1.49M-91.52%-1.42M-46.44%-5.11M---743K---3.49M
Operating gains losses -----------1K--------
Depreciation and amortization --7K-46.67%8K-21.05%45K--15K--57K
Other non cash items --83K747.62%136K218.66%318K---21K---268K
Change In working capital --302K-160.31%-505K-63.60%87K---194K--239K
-Change in receivables --2K-500.00%-44K145.00%18K--11K---40K
-Change in prepaid assets ---63K-1,742.86%-129K-179.28%-329K---7K--415K
-Change in payables and accrued expense --364K-149.02%-381K993.88%438K---153K---49K
-Change in other working capital ---1K208.89%49K54.02%-40K---45K---87K
Cash from discontinued investing activities
Operating cash flow ---1.07M-92.32%-1.75M-35.80%-4.53M---911K---3.34M
Investing cash flow
Cash flow from continuing investing activities 0-101.18%-6K209.35%573K507K-524K
Net PPE purchase and sale --0---6K265.00%66K--0---40K
Net investment purchase and sale --0--0204.75%507K--507K---484K
Cash from discontinued investing activities
Investing cash flow --0-101.18%-6K209.35%573K--507K---524K
Financing cash flow
Cash flow from continuing financing activities 0-81.03%522K02.75M
Net preferred stock issuance --0-----81.01%522K------2.75M
Proceeds from stock option exercised by employees --0------0--0--3K
Cash from discontinued financing activities
Financing cash flow --0--0-81.03%522K--0--2.75M
Net cash flow
Beginning cash position --2.83M-44.10%4.65M-17.59%8.31M--8.31M--10.08M
Current changes in cash ---1.07M-335.15%-1.76M-210.21%-3.43M---404K---1.11M
Effect of exchange rate changes ---19K-394.74%-56K65.52%-230K--19K---667K
End cash Position --1.75M-64.27%2.83M-44.10%4.65M--7.92M--8.31M
Free cash flow ---1.07M-92.97%-1.76M-34.55%-4.54M---911K---3.38M
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg